Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 224 clinical trials
Featured trial
Auricular Acupressure for Premenstrual Syndrome in Female Students

  • Be monitored for any adverse effects during the 8-week trial period.
    • ul>

    Online studies
    • 0 views
    • 23 May, 2025
    • Online study
    Featured trial
    The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease (LIBRA)

  • Treatment duration: 52-week double-blind period (Part A); LTE period (Part B) from the (FPI until the last participant who enters the LTE has completed 52 weeks
  • Visit frequency: Week visits based on the Schedule of Assessments
    • ul>

    Online studies
    • 0 views
    • 18 May, 2025
    • Online study
    Featured trial
    l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee) (123)

    This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)

    Online studies
    Accepts healthy volunteers
    • 0 views
    • 19 May, 2025
    • Online study
    Featured trial
    Test RTE

    Study Overview Study Details Eligibility Trial Primary Objective:
    To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
    Secondary Objectives:
    To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
    To continue to …

    • 0 views
    • 19 Feb, 2024
    Featured trial
    Study on the Visual Condition in Parkinson's Disease  

    Non motor symptoms and signs in Parkinson's disease (PD) also include a series of visual deficits; deepening these aspects could be useful for a better management of symptoms, to standardize a specific protocol for the issues related to vision and also to understand how these aspects are important for the …

    motor symptoms
    parkinson's disease
    • 0 views
    • 19 Feb, 2024
    • 2 locations
    A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707)  

    ul>

    • 0 views
    • 04 Apr, 2025
    • 1 location
    • Online study
    Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

  • To document the real-world effectiveness and safety of treatments.
    • ul>

    • 0 views
    • 23 May, 2025
    • 1 location
    A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (ZEN)

    This is a parallel, Phase 2, 3-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult participants with moderate to severe HS aged ≥18 to 70 years.

    Study details include:

    <ul>
  • Screening period: up to 4 weeks (30 days)
  • Treatment duration: up to 16 weeks
  • Follow-up period: …

    • 0 views
    • 09 May, 2025
    SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients  

  • The primary objective is to determine whether SAR408701 improves the overall survival (OS) when compared with docetaxel in participants with metastatic non-squamous NSCLC expressing CEACAM5 2+ in intensity in at least 50% of the tumor cell population and previously treated with standard-of-care platinum-based chemotherapy and an immune checkpoint inhibitor.
    • ul>

    …

    docetaxel
    pulmonary metastasis
    small cell lung cancer
    non-small cell lung cancer
    squamous non-small cell lung cancer
    • 0 views
    • 19 Feb, 2024
    • 52 locations
    A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

    Eligible participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during induction phase:-

    <ul>
  • Arm A: Tiragolumab plus atezolizumab and CE
  • Arm B: Placebo plus atezolizumab and CE
    • ul>

    Following the induction phase, participants will continue maintenance therapy with either atezolizumab …

    extensive stage small cell lung cancer
    extensive stage sclc
    etoposide
    small cell lung cancer
    maintenance therapy
    • 0 views
    • 19 Feb, 2024